Invesco S&P 500 Equal Weight Health Care ETF RSPH

Invesco S&P 500 Equal Weight Health Care ETF es un activo que puedes comprar desde Chile con Racional. Conoce a qué se dedica, cómo se compone y qué lo mueve en el mercado, junto con sus datos clave para decidir si calza con tus metas de largo plazo.

Con 27 acciones de RSPH (USD 1.006,29) habrías recibido USD 5,94 en dividendos en los últimos 12 meses.

RSPH hizo una división de acciones (split) de 10:1 el 17 de julio de 2023: cada acción se convirtió en 10. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 31 ago

  Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

  RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.

  

• The Motley Fool 21 jul

  IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?

  IXJ and RSPH are two healthcare ETFs with different strategies: IXJ uses cap-weighted global exposure with larger pharmaceutical companies, offering higher dividends (1.47%) and lower volatility (beta 0.52), while RSPH employs equal-weighting of S&P 500 healthcare stocks, providing stronger 1-year returns (21.01% vs 18.29%) but higher risk (beta 0.81). The choice depends on investor goals—IXJ suits conservative/income-focused investors, while RSPH appeals to growth-oriented investors willing to accept volatility.

  

• The Motley Fool 16 jul

  Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

  The iShares Global Healthcare ETF (IXJ) outperformed the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) over the past five years, delivering stronger total returns (1.50% dividend yield vs. 0.70%), lower volatility (beta of 0.56 vs. 0.78), and a shallower maximum drawdown. While both funds charge identical 0.40% expense ratios, IXJ's market-cap weighting and international exposure of 110 global healthcare stocks provide broader diversification compared to RSPH's 60 U.S. large-cap equal-weighted holdings.